SCHEMBL30384245

SCHEMBL30384245

O=C(O)CCCOc1ccc(C(=O)/C=C/c2cccc(O)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 2/20 0.57
▸ BCHE P06276 9/20 0.57
▸ ACHE P22303 8/20 0.57
▸ PPARA Q07869 2/20 0.56
▸ PTPN1 P18031 1/20 0.55
▸ ESR1 P03372 1/20 0.54
▸ MAOA P21397 1/20 0.54
▸ MAOB P27338 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25284515 1.00 ABCG2 (0.57) ABCG2BCHEACHEPPARAPTPN1
SCHEMBL25193715 0.89 BCHE (0.70) BCHEACHEPPARAMAOAMAOB
SCHEMBL30382732 0.88 PTPN1 (0.56) BCHEACHEPPARAPTPN1MAOA
SCHEMBL30383329 0.88 MAOB (0.62) BCHEACHEPPARAMAOAMAOB
SCHEMBL30383044 0.88 MAOA (0.58) BCHEACHEPPARAMAOAMAOB
SCHEMBL25243102 0.88 MAOB (0.62) BCHEACHEPPARAMAOAMAOB
SCHEMBL25234108 0.88 MAOA (0.58) BCHEACHEPPARAMAOAMAOB
SCHEMBL25233299 0.88 PTPN1 (0.56) BCHEACHEPPARAPTPN1MAOA
SCHEMBL25278972 0.88 BCHE (0.55) BCHEACHEPPARAMAOAMAOB
SCHEMBL30383397 0.88 BCHE (0.55) BCHEACHEPPARAMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233598-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2024-11-14 — — WO disclosed
EP-4429763-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS Yewsavin, Inc. (US) 2024-09-18 — — EP disclosed
WO-2023086388-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-05-19 — — WO disclosed
Send feedback